4.4 Article

Algorithm-based decision support for symptom self-management among adults with Cancer: results of usability testing

Journal

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/S12911-018-0608-8

Keywords

Rule-based clinical decision support; Symptom management; Patient engagement; Patient self-management; Cancer

Funding

  1. Patient Centered Outcomes Research Institute [PI-12-001]

Ask authors/readers for more resources

Background: It is essential that cancel patients understand anticipated symptoms, how to self-manage these symptoms, and when to call their clinicians. However, patients are often ill-prepared to manage symptoms at home. Clinical decision support (CDS) is a potentially innovative way to provide information to patients where and when they need it. The purpose of this project was to design and evaluate a simulated model of an algorithm- based CDS program for self-management of cancer symptoms. Methods: This study consisted of three phases; development of computable algorithms for self-management of cancer symptoms using a modified ADAPTE process, evaluation of a simulated model of the CDS program, and identification of design objectives and lessons learned from the evaluation of patient-centered CDS. In phase 1, algorithms for pain, constipation and nausea/vomiting were developed by an expert panel. In phase 2, we conducted usability testing of a simulated symptom assessment and management intervention for self-care (SAMI-Self-Care) CDS program involving focus groups, interviews and surveys with cancer patients, their caregivers and clinicians The Acceptability E-scale measured acceptability of the program. In phase 3, we developed design objectives and identified barriers to uptake of patient-centered CDS based on the data gathered from stakeholders. Results: In phase 1, algorithms were reviewed and approved through a consensus meeting and majority vote. In phase 2, 24 patients & caregivers and 13 clinicians participated in the formative evaluation. Iterative changes were made in a simulated SAMI-Self-Care CDS program. Acceptability scores were high among patients, caregivers and clinicians. In phase 3, we formulated CDS design objectives, which included: 1) ensure patient safety, 2) communicate clinical concepts effectively, 3) promote communication with clinicians, 4) support patient activation, and 5) facilitate navigation and use. We identified patient barriers and clinician concerns to using CDS for symptom self-management, which were consistent with the chronic care model, a theoretical framework used to enhance patient-clinician communication and patient self- management. Conclusion: Patient safety and tool navigation were critical features of CDS for patient self-management. Insights gleaned from this study may be used to inform the development of CDS resources for symptom self-management in patients with other chronic conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Health Care Sciences & Services

Insights from Bereaved Family Members About End-of-Life Care and Bereavement

Sue E. Morris, Manan M. Nayak, Susan D. Block

JOURNAL OF PALLIATIVE MEDICINE (2020)

Letter Oncology

Oncologists' perspectives on medical marijuana use by older adults

Desiree R. Azizoddin, Andrea C. Enzinger, Alexi A. Wright, Miryam Yusufov, James A. Tulsky, Eric G. Campbell, Dragana Bolcic-Jankovic, Manan M. Nayak, Ilana M. Braun

JOURNAL OF GERIATRIC ONCOLOGY (2020)

Article Oncology

Cancer patients' experiences with medicinal cannabis-related care

Ilana M. Braun, Manan M. Nayak, Anna Revette, Alexi A. Wright, Peter R. Chai, Miryam Yusufov, William F. Pirl, James A. Tulsky

Summary: Patients with cancer using medical cannabis often lack medical oversight, with certifications typically issued after brief consultations with unfamiliar professionals. Patients frequently rely on personal experimentation and nonmedical sources for information about medical cannabis.

CANCER (2021)

Article Genetics & Heredity

Informing models of cancer genetic care in the era of multigene panel testing with patient-led recommendations

Meghan Underhill-Blazey, Traci Blonquist, Anu Chittenden, Rachel Pozzar, Manan Nayak, Kristina Lansang, Fangxin Hong, Judy Garber, Jill E. Stopfer

Summary: The study describes the patient-reported experiences and recommendations to improve the genetic counseling and multigene panel testing process. Most participants reported satisfaction with the process. The study found that factors such as age, marital status, education level, type of cancer diagnosis, and genetic testing results were significantly associated with satisfaction levels.

JOURNAL OF GENETIC COUNSELING (2021)

Article Oncology

Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer

Rachel A. Pozzar, Fangxin Hong, Niya Xiong, Jill E. Stopfer, Manan M. Nayak, Meghan Underhill-Blazey

Summary: This study aimed to explore factors associated with the psychosocial impact and cancer genetics knowledge in ovarian cancer patients undergoing genetic counseling and testing. Positive genetic test results were linked to greater adverse psychosocial impacts, while older age and minority racial or ethnic group membership were associated with lower knowledge levels. Patients expressed a desire for clinicians to support family communication, improve result disclosure, and enhance understanding of results.

FAMILIAL CANCER (2022)

Letter Oncology

United States oncologists' clinical preferences regarding modes of medicinal cannabis use

Timothy S. Sannes, Manan M. Nayak, Stephanie Tung, Peter R. Chai, Miryam Yusufov, Dragana Bolcic-Jankovic, William F. Pirl, Ilana M. Braun

CANCER COMMUNICATIONS (2021)

Article Health Care Sciences & Services

Cancer Patients' Experiences with and Perspectives on the Medicinal Cannabis High

Stephanie C. Tung, Manan M. Nayak, Peter R. Chai, James Tulsky, Timothy S. Sannes, Miryam Yusufov, Ilana M. Braun

Summary: Patients with cancer use medicinal cannabis for symptom management and cancer-directed therapy. The high experienced from medicinal cannabis is seen as a barrier to its use and patients try to avoid prolonged periods of being high.

JOURNAL OF PALLIATIVE MEDICINE (2022)

Article Substance Abuse

Feasibility of collecting computer-facilitated patient-reported tobacco use, interest, and preferences for smoking cessation in an outpatient thoracic surgery and oncology setting

Manan M. Nayak, Emanuele Mazzola, Michael T. Jaklitsch, Jeremy E. Drehmer, Emara Nabi-Burza, Raphael Bueno, Jonathan P. Winickoff, Mary E. Cooley

Summary: The objective of this study was to determine the feasibility of using a computer-facilitated system to screen for tobacco use and provide smoking cessation services in an outpatient thoracic surgery and oncology setting. The results showed that implementing such a system was feasible and about half of the smokers were interested in receiving smoking cessation treatment.

TOBACCO INDUCED DISEASES (2022)

Article Oncology

Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel

Ilana M. Braun, Manan M. Nayak, Jane E. Roberts, Peter R. Chai, James A. Tulsky, Donald I. Abrams, William Pirl

Summary: The study found that cannabis dispensary personnel are passionate about their profession but lack standardized and high-quality training, resulting in uneven levels of knowledge. Therefore, there is a need for quality, standardized cannabis therapeutics training for dispensary personnel.

JCO ONCOLOGY PRACTICE (2022)

Article Medicine, Research & Experimental

Protocol for a randomized controlled trial of the Enhanced Smoking Cessation Approach to Promote Empowerment (ESCAPE) digitalized intervention to promote lung health in high-risk individuals who smoke

Mary E. Cooley, Peter J. Castaldi, Emanuele Mazzola, Meghan Underhill Blazey, Manan M. Nayak, Michael J. Healey, Christopher S. Lathan, Andrea Borondy-Kitts, Rosanna F. DeMarco, Sun S. Kim

Summary: Low dose computed tomography (LDCT) is an effective screening test for reducing lung cancer deaths and may serve as a teachable moment for smoking cessation. Innovative strategies are needed to engage high-risk individuals in learning about LDCT screening. Polygenic risk scores and personalized interventions can improve precision health and tobacco cessation programs.

CONTEMPORARY CLINICAL TRIALS (2023)

Article Oncology

Medical cannabis-related stigma: cancer survivors' perspectives

Manan M. Nayak, Anna Revette, Peter R. Chai, Kristina Lansang, Timothy Sannes, Stephanie Tung, Ilana M. Braun

Summary: This study found that medical cannabis-related stigma is widespread among cancer patients, particularly in medical settings. Some participants chose to hide their use of medical cannabis. The findings also suggest that there may be an early shift towards greater acceptance of medical cannabis, especially in non-medical settings.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Article Oncology

Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021

Sayantani Sarkar, Ilana M. Braun, Manan Nayak, Angela D. Bryan, Hermine Poghosyan

Summary: This study estimated the prevalence and reasons for cannabis use among cancer survivors during the COVID-19 pandemic. The prevalence of past 30-day cannabis use remained stable during the pandemic, with a percentage of users reporting medical reasons. The study also identified specific subpopulations of cancer survivors who were more likely to use cannabis.

JNCI CANCER SPECTRUM (2023)

Article Oncology

Dispensary personnel's views and experiences regarding oncologic cannabis and the counsel they offer adults with cancer

Manan M. Nayak, Peter R. Chai, Stephanie Tung, James A. Tulsky, Marilyn Hammer, Nicole Andrade, Ilana M. Braun

Summary: This study explored the views and experiences of dispensary personnel regarding the use of medicinal cannabis in cancer patients. The majority of dispensary personnel believed that cannabis could effectively manage cancer-related symptoms, but opinions on its antineoplastic potential varied. They recommended client-centered, symptom-based, and trial-and-error approaches when serving cancer patients, with non-inhalation modes of administration generally being preferred. Challenges in oncologic advising included identifying patients, financial toxicity, and lack of standardized guidelines.

CANCER MEDICINE (2023)

Letter Pharmacology & Pharmacy

Letter to the Editor: The Role of Cannabidiol in Cancer Care: Oncologist and Cancer Patient Perspectives

Manan M. Nayak, Peter R. Chai, Stephanie Tung, Timothy S. Sannes, Miryam Yusufov, Ilana M. Braun

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Psychology, Social

Cancer patient's attitudes of using medicinal cannabis for sleep

Eric S. Zhou, Manan M. Nayak, Peter R. Chai, Ilana M. Braun

Summary: The study found that the majority of cancer patients use medicinal cannabis to improve sleep, reporting better sleep initiation and quality, decreased use of sleep medications, and overall improved health as a result. No participants reported ineffectiveness or undesirable side effects when using medicinal cannabis for sleep.

JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2022)

No Data Available